MedPath

沈阳福宁药业有限公司

Ownership
-
Established
2004-06-02
Employees
-
Market Cap
-
Website
www.syfnyy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

16

NMPA:16

Drug Approvals

Bupropion Hydrochloride Sustained-release Tablets

Product Name
盐酸安非他酮缓释片
Approval Number
国药准字H20080111
Approval Date
Feb 14, 2023
NMPA

Lanthanum Carbonate Chewable Tablets

Product Name
碳酸镧咀嚼片
Approval Number
国药准字H20233125
Approval Date
Feb 7, 2023
NMPA

Clotrimazole Vaginal Effervescent Tablets

Product Name
克霉唑阴道泡腾片
Approval Number
国药准字H20064776
Approval Date
Oct 21, 2020
NMPA

Trazodone Hydrochloride Tablets

Product Name
盐酸曲唑酮片
Approval Number
国药准字H20133205
Approval Date
May 29, 2020
NMPA

Trazodone Hydrochloride Tablets

Product Name
盐酸曲唑酮片
Approval Number
国药准字H20060037
Approval Date
May 29, 2020
NMPA

Tamoxifen Citrate Tablets

Product Name
枸橼酸他莫昔芬片
Approval Number
国药准字H21024159
Approval Date
May 29, 2020
NMPA

Trazodone Hydrochloride Tablets

Product Name
舒绪
Approval Number
国药准字H20050223
Approval Date
May 12, 2020
NMPA

Calcium Acetate Tablets

Product Name
醋酸钙片
Approval Number
国药准字H20203130
Approval Date
Mar 31, 2020
NMPA

Compound Sulfamethoxazole Tablets

Product Name
复方磺胺甲噁唑片
Approval Number
国药准字H21021647
Approval Date
Aug 15, 2015
NMPA

Norfloxacin Capsules

Product Name
诺氟沙星胶囊
Approval Number
国药准字H21021648
Approval Date
Aug 15, 2015
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.